Medication info
Diarrhite Tablet 4 mg (Glimepiride)

Diarrhite Tablet 4 mg (Glimepiride)

Prescription medicationTablet경구
Ingredient · strength
Glimepiride›4mg / 1 tablet
Manufacturer / importer
광동제약(주)
Appearance
Pale blue rectangular tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 200704613 · Notified 2007.04.20 · Insurance code 641801260

Summary

Main use
Improvement of blood sugar control in Type 2 diabetes
Who takes it
Adults
Adult dose
This medication is taken orally once daily before breakfast or just before the first meal. The initial dose is 1 mg of Glimepiride taken once daily, which can be increased by 1 mg at intervals of 1 to 2 weeks. Generally, the maximum dose is up to 4 mg, with a possibility of increasing to 6 mg or 8 mg if necessary. It is very important not to skip meals after taking this medication. In combination therapy with insulin.

Ingredients

Manufacturer
광동제약(주)

Efficacy & effects

Improvement of blood sugar control in Type 2 diabetes

View approved original text

This medication is used alongside dietary and exercise therapy to help manage blood sugar levels in patients with Type 2 diabetes. It can be administered alone but may also be combined with other hypoglycemic agents for more effective blood sugar management. Particularly, when used with insulin or metformin, better blood sugar control can be expected. This medication helps improve blood sugar management and assists in the treatment of diabetes.

How to take

Adult dose

This medication is taken orally once daily before breakfast or just before the first meal. The initial dose is 1 mg of Glimepiride taken once daily, which can be increased by 1 mg at intervals of 1 to 2 weeks. Generally, the maximum dose is up to 4 mg, with a possibility of increasing to 6 mg or 8 mg if necessary. It is very important not to skip meals after taking this medication. In combination therapy with insulin.

Precautions

This medication should not be used in patients with insulin-dependent diabetes, diabetic ketoacidosis, or in a comatose state. Additionally, it is not safe to administer to patients who have had allergic reactions to this medication or similar drugs, those with severe liver or kidney dysfunction, pregnant or breastfeeding women, and patients with severe infections or post-surgical patients. During the first week of taking this medication, there is a higher risk of hypoglycemia, so blood sugar levels should be closely monitored, especially in elderly patients, those with poor nutritional status or irregular eating patterns, and those who frequently consume alcohol. Symptoms of hypoglycemia may include headaches, severe hunger, nausea, fatigue, confusion, drowsiness, and decreased consciousness, so if any of these symptoms occur, immediate intake of sugar and consultation with medical staff is necessary. This medication can affect liver and kidney function, so regular testing is required, and any unusual symptoms should be reported immediately. Furthermore, when taken with other medications, interactions can affect blood sugar control, so all medications currently taken should be disclosed to healthcare professionals. It is advisable for pregnant or breastfeeding women not to use this medication and to switch to insulin therapy if necessary. Safety in children has not been established, so it is preferable to avoid use in individuals under 18 years of age. Excessive doses can lead to severe hypoglycemia, so it is essential to adhere to the prescribed dosage and seek emergency treatment immediately if an overdose is suspected. This medication should be kept out of the reach of children and stored in the original container sealed to maintain its quality and safety.

Side effects and when to seek care immediately

Serious side effects

Hives, severe swelling (edema), difficulty breathing, hypotension, shock, erythema multiforme (Stevens-Johnson syndrome), anaphylaxis, angioedema, liver dysfunction (cholestatic jaundice, hepatitis), serious blood changes (thrombocytopenia, leukopenia, hemolytic anemia, anemia, agranulocytosis, pancytopenia), thrombocytopenic purpura, severe hypoglycemia (seizures, loss of consciousness, coma), and hypoglycemic episodes.

Mild side effects

  • Headaches
  • severe hunger
  • nausea
  • vomiting
  • fatigue
  • sleep disturbances
  • anxiety
  • aggression
  • decreased concentration
  • reduced agility or activity
Show 24 more
  • depression
  • confusion
  • speech anomalies
  • aphasia
  • visual disturbances
  • tremors
  • incomplete paralysis
  • sensory disturbances
  • dizziness
  • weakness
  • loss of self-control
  • transient mental confusion
  • drowsiness
  • shallow breathing
  • bradycardia
  • sweating
  • cool moist skin
  • tachycardia
  • hypertension
  • palpitations
  • angina pectoris
  • deep vein thrombosis
  • blurred vision
  • upper abdominal pain.

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should always be stored in a tightly sealed container. Additionally, to maintain the medication's efficacy, it is important to store it at a temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

Pale blue rectangular tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.